In non-immune TME, tumor cell growth is mainly regulated by the PI3K/AKT/mTOR signaling pathway, RAS/RAF/MAPK signaling pathway, and WNT/β-catenin signaling pathway (Figure 2). This evidence concerns the gene AKT1 and neoplasm.